Skip to content
Screener

Ethos Technologies, Inc. LIFE Price / book

Price / book at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
5.3×-0.2×
Merck & Co. logo
Merck & Co.MRK
6.5×+1.8×
United Therapeutics logo
United TherapeuticsUTHR
4.4×+2.4×
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
3.4×+1.6×
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
49.5×+44.6×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
4.9×+3.8×

Other financials

Income statement

See full
Revenue-—
Operating income-$11.4M+27.5%
Net income-$10.8M+27.5%
EPS (diluted)-$0.11+35.3%

Balance sheet

See full
Cash & equivalents$10.0M-3.4%
Total debt$12.3M-9.2%
Total equity$57.9M-22.8%
Total assets$79.7M-18.1%

Cash flow

See full
Operating cash flow-$12.5M+18.8%
CapEx$138.0K—
Free cash flow-$12.7M+17.9%

Valuation

See full
Market cap$1.29B+36.1%
Enterprise value$1.29B—

Profitability

See full
Operating margin-40,856.3%+28,833pp
Net margin-39,009.5%+29,653pp
FCF margin-32,664.7%+4,018pp

Returns & leverage

See full
Return on equity-105.3%+50.6pp
Debt / equity0.2×0.0×
Current ratio5.8×-2.0×

Where this comes from

Calculated from Ethos Technologies, Inc. ’s reported figures.

market cap/total stockholders equity=12.1×

Based on the most recent quarter.

The source filing: Ethos Technologies, Inc. ’s 10-Q, filed May 15, 2026. Open the filing →

Filed
May 15, 2026, 4:01 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001339970-26-000033

FAQ

What is Ethos Technologies, Inc. 's price / book?
Ethos Technologies, Inc. (LIFE) reported price / book of 12.1× in Q1 2026.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Ethos Technologies, Inc. 's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude